Artificial Heart - new breakthroughs in medicine

Artificial heart transplants for the first time in the history of medicine has been successfully implemented by the French scientist 18th / 12/2013. 75 years- male patients who were transplanted heart was awake, talking normally and meet at Hospital Georges Pompidou, Paris.

Experts said they are delighted with this first success, the patient is being monitored and will soon be a special time to hospital discharge. Artificial heart can help patients live for 5 years. After surgery, the patient can return home and continue working.

French surgeons have successfully implanted artificial heart in humans

Artificial heart operation Lithium-ion battery, weighs about 900 grams - almost three times that of a normal healthy heart. It has the ability to mimic the activity of the heart muscle contractions and contains sensors to adapt to the circulatory motion of the patient. The surface of the artificial heart blood contact is made ​​from cow heart tissue, instead of artificial materials such as plastics can cause blood clots and other complications. It is expected to cost around £ 150,000 (equivalent to more than 5 billion Vietnam) if implemented widely.

With this success, hoping to help thousands of heart disease each year have the opportunity to prolong surgery. According to estimates by Carmat - the company designed the artificial heart, there are about 100,000 people in the European countries and the United States need heart surgery.

Health Minister Marisol Touraine (left) and Alain Carpentier, a surgeon at a press conference at the European Hospital Georges Pompidou in Paris

The surgeon Alain Carpentier said: "This method will return the patient to a normal social life with the least dependent on drugs." Ms. Marisol Touraine, French Health Minister says with pride . "As pioneers in medicine, we have been implementing an innovation brings great hope for many people."
Heart failure affects more men than women, and the size of the current artificial heart can fit about 86% of men and only 20% of women. However, the manufacturer can make a smaller version to fit a woman's body as the disease of Asia.